Basu s p (33 résultats)

Pbk. Contents. 1. Introduction. 2. Classified list of species of hemiptera from Namdapha. 3. Systematic account. Summary. Acknowledgements. References. 42 pp.

Etat : Good. This is an ex-library book and may have the usual library/used-book markings inside.This book has soft covers. In good all round condition. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,500grams, ISBN:9781405130776.

Etat : New. pp. 410.

Etat : New. pp. 410.

Etat : New. pp. 410.

Etat : Please see description. Original cloth with dustjacket. Spine of the dustjacket a bit discolored / bit worn at edges, minor traces of use. else a good copy. Text in English.

Hardcover. Etat : New. ISBN:9789390425549.

BINDING - Hardcover. Etat : CONDITION - used/Average. Etat de la jaquette : Jacket - Fair. with some wear. 1st Edition. 84 Pages. 16 Plates. 3/4 Pin Holes. Jacket Worn With Loss.

Etat : New. pp. 356 Index.

Etat : New. pp. 330 Acknowledgements.

Hardcover. Etat : Good. Etat de la jaquette : good.

Etat : New.

Etat : New.

Couverture souple. Etat : Bon. Un volume in8,broché,( 14,3 x 22,7 cm),147 pages,dos insolé,signature sur le plat et la page de faux titre . Rare.

Soft cover. Etat : Good. No Jacket. Second Supplementary Catalogue of Coins to Vol. 1, the. Book.

Hardcover. Etat : New. 1034pp.

Leather Bound. Etat : New. Reprint. 1034pp, Hand crafted leather binding.

Hardcover. 383pp., with 15 plates. Bottom of spine and bottom corners are worn to the boards. but the text is clean and unmarked and the binding is sound without a dust jacket.

Etat : New.

Taschenbuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - The biotechnology business in India with an increase from USD 500 million in 1997 and reaching an estimated USD I billion next year health related prod ucts accounting for 60%, agro and veterinary products together 15%, and con tract R&D, reagents, devices and supplies adding up to the remaining 25% of which the diagnostics share was about 10% of the total surely presented an encouraging picture even five years ago. While volumes have increased, the pat tern has not. According to a report, prepared by McKinsey & Co, India's Phar maceutical industry including domestic and export sales and contract services totals nearly USD 5 billion. Furthermore, the company optimistically projects the growth to a factor of five fold only if both the industry and the government are able to put in place achievable solutions that must take care of the formida ble obstacles preventing further growth. If this assessment is correct, then the established transformation made by IT growth should also provide the confi dence required by the high expectations for biotechnology which have arisen in the country in recent years. Some contributors to this are overenthusiastic these are bureaucrats, some retired scientists and of course the complacent politicians who have the least knowledge of what the new biotechnology is all about. However, there are clear indications of biotechnology growth demon strated by a few but rapidly expanding biotech companies such as Biocon Ltd, Shantha Biotech (P) Lid, Dr. …

Etat : New. This review series covers trends in modern biotechnologyAll aspects of this interdisciplinary technology, where knowledge, methods and expertise are required from chemistry, biochemistry, microbiology, genetics, chemical engineering and computer s.

Hardcover. Etat : Good. Good. Dust Jacket NOT present. CD WILL BE MISSING. . SHIPS FROM MULTIPLE LOCATIONS. book.

Etat : New.

Etat : New.

Paperback. Etat : Brand New. 312 pages. 9.25x6.10x0.74 inches. In Stock.

Etat : As New. Unread book in perfect condition.

Etat : As New. Unread book in perfect condition.

Buch. Etat : Neu. Neuware - The biotechnology business in India with an increase from USD 500 million in 1997 and reaching an estimated USD I billion next year health related prod ucts accounting for 60%, agro and veterinary products together 15%, and con tract R&D, reagents, devices and supplies adding up to the remaining 25% of which the diagnostics share was about 10% of the total surely presented an encouraging picture even five years ago. While volumes have increased, the pat tern has not. According to a report, prepared by McKinsey & Co, India's Phar maceutical industry including domestic and export sales and contract services totals nearly USD 5 billion. Furthermore, the company optimistically projects the growth to a factor of five fold only if both the industry and the government are able to put in place achievable solutions that must take care of the formida ble obstacles preventing further growth. If this assessment is correct, then the established transformation made by IT growth should also provide the confi dence required by the high expectations for biotechnology which have arisen in the country in recent years. Some contributors to this are overenthusiastic these are bureaucrats, some retired scientists and of course the complacent politicians who have the least knowledge of what the new biotechnology is all about. However, there are clear indications of biotechnology growth demon strated by a few but rapidly expanding biotech companies such as Biocon Ltd, Shantha Biotech (P) Lid, Dr.…

Etat : As New. Unread book in perfect condition.

Gr.-8°, Softcover/Paperback. Etat : Gut. 68 S. + zahlreiche Abbildungen Buch in gutem Zustand, Einband mit leichten Gebrauchsspuren und beschrieben, Titelblatt beklebt Sprache: Englisch Gewicht in Gramm: 490.